GNH USA

Europe — EMA

Nebilet (Nebivolol)

GNH USA supplies Nebilet (Nebivolol), a beta‑blocker for hypertension and chronic heart failure, meeting international quality standards.

Nebivolol

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebilet, is a beta‑blocker presented as a tablet for oral use. It treats hypertension and chronic heart failure in adult patients.

GNH USA supplies Nebilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nebivolol used for?

Nebivolol is used in cardiovascular therapy to control blood pressure and support heart function.

Hypertension: lowers systolic and diastolic blood pressure, helping to prevent cardiovascular complications. Chronic heart failure: improves left ventricular ejection fraction and reduces risk of hospitalization.

What are the side effects of Nebivolol?

Nebivolol may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Fatigue or tiredness - Headache - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Nasal congestion - Mild gastrointestinal discomfort (nausea, abdominal pain)

Serious or Rare Side Effects: - Severe bradycardia or heart block - Worsening of heart failure symptoms - Bronchospasm in patients with reactive airway disease - Allergic reactions such as rash, angioedema, or anaphylaxis - Hepatic dysfunction or elevated liver enzymes

What precautions apply to Nebivolol?

Before prescribing Nebilet, clinicians should consider several safety factors.

Cardiovascular assessment: evaluate heart rate and blood pressure prior to initiation. Respiratory conditions: use with caution in patients with asthma or COPD. Diabetes monitoring: monitor blood glucose as beta‑blockade may mask hypoglycaemia symptoms. Renal impairment: dose adjustment may be required in severe renal dysfunction. Drug discontinuation: taper gradually to avoid rebound hypertension. Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

What does Nebivolol interact with?

Nebivolol can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other beta‑blockers or non‑selective beta‑blockers: additive bradycardia. - Calcium‑channel blockers verapamil or diltiazem: risk of severe bradycardia or AV block. - Potent CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine): increase nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypotensive effect. - NSAIDs: may attenuate blood‑pressure‑lowering response.

Frequently asked questions

What is Nebilet used for?+
Nebilet contains nebivolol, a selective β1‑blocker indicated for the treatment of essential hypertension and for chronic heart failure in adults. By lowering blood pressure and improving cardiac output, it helps reduce the risk of cardiovascular events and hospitalisation associated with these conditions.
How does nebivolol work?+
Nebivolol works by selectively blocking β1‑adrenergic receptors in the heart, which slows heart rate and reduces contractile force. It also stimulates endothelial nitric‑oxide production, causing vasodilation and lowering peripheral vascular resistance. The combined actions lower arterial pressure while preserving β2‑mediated bronchodilation.
What is the usual dose of Nebilet?+
The dose of nebivolol is individualized. A qualified prescriber determines the appropriate starting dose, titration schedule, and maintenance dose based on the patient’s clinical condition, age, renal function and response to therapy. Patients should follow the prescribing information provided by their healthcare professional.
Is nebivolol safe during pregnancy or breastfeeding?+
Safety data for nebivolol in pregnancy are limited, and the drug is generally avoided unless the potential benefit justifies the risk. It is excreted in breast‑milk, so breastfeeding mothers should discuss alternatives with their physician, as the risk to the infant is not well established.
How do I order Nebilet from GNH USA?+
To request Nebilet, submit an enquiry on the product page at gnh-usa.com indicating the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.
How does nebivolol compare with other beta‑blockers?+
Nebivolol is a third‑generation, β1‑selective blocker that also promotes nitric‑oxide‑mediated vasodilation, giving it a more favourable metabolic profile and fewer bronchospastic effects compared with non‑selective agents. It may be preferred in patients who need blood‑pressure control without compromising peripheral circulation or respiratory function.
How should Nebilet be stored and handled?+
Nebilet tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.
How is Nebilet administered?+
Nebilet is taken orally, usually once daily, with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless the prescriber specifically advises an alternative method.
What are the most serious risks associated with Nebilet?+
Serious adverse events include severe bradycardia, heart block, worsening heart failure, bronchospasm in patients with reactive airway disease, and rare cases of hepatic dysfunction or severe allergic reactions. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, difficulty breathing, or signs of an allergic reaction.
Who should not use Nebilet?+
Nebilet is contraindicated in patients with known hypersensitivity to nebivolol or any excipients, those with severe bradycardia (heart rate <50 bpm), second‑ or third‑degree atrioventricular block, cardiogenic shock, or decompensated heart failure. Caution is also advised for individuals with uncontrolled asthma, severe peripheral vascular disease, or significant hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Menarini International Operations Luxembourg S.A.
Origin
EU

Related products

Nebivolol 20 mg/1

Nebivolol 20 mg/1

Nebivolol · 20 mg

nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 2.5 mg/1

NEBIVOLOL 2.5 mg/1

Nebivolol · 2.5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 5 mg/1

NEBIVOLOL 5 mg/1

Nebivolol · 5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 10 mg/1

NEBIVOLOL 10 mg/1

Nebivolol · 10 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA